2017 Research Update: Intense Study, Rapid Progress

PC: Alzheimer’s Orange County

March 15, 2017

On March 14, UCI MIND’s community partner, Alzheimer’s Orange County, held their annual Research Update on Alzheimer’s disease at the Bowers Museum. The update was, for the second straight year, delivered by UCI MIND Co-Director, Dr.
more >


“Patients ‘relieved’ by amyloid scans” 

 

MedPage Today

February 8, 2017

Learn more about a recent research study conducted by UCI MIND Co-Director, Dr. Joshua Grill, and colleagues to better understand patient and caregiver reactions to clinical amyloid imaging.

Read more> more >



Research Suggests Space Travel Affects the Brain

U.S. News & World Report
February 6, 2017

“This is not a deal-breaker,” co-author Charles Limoli, a neurobiologist at the University of California, Irvine, said last fall. “I do not think that during the course of a trip to Mars and back the astronauts will come back with anything remotely similar to full-blown Alzheimer’s. more >



UCI MIND featured on KCAL9/CBS2 2 nights in a row

December 1, 2016

KCAL9/CBS2

If you missed UCI MIND Gala Co-Chairs, Lucy &  Roger Lisabeth, on KCAL 9 last night, tune into CBS 2 Los Angeles tonight at 5pm with Elsa Ramon to hear their powerful story.

Learn more about what the Lisabeths and UCI MIND are doing in the fight against Alzheimer’s disease here. more >



Register for next Friday’s conference today!

14352017_1281158748584978_7319718426746265540_o

Education is essential to help increase awareness of Alzheimer’s disease and related dementias. Join us for our biggest education event of the year next Friday, September 30, at the Irvine Marriott. Click here to learn more and register!

 

14362692_1281182715249248_1525923504724460869_o


 

 

 

 

  more >



The UCI Consent 2 Contact Registry

c2c-old-manResearch is the key to finding treatments and cures for Alzheimer’s disease and other urgent health problems. If you or someone you know is interested in helping researchers at UCI find cures faster, check out our new online potential participant registry, Consent 2 Contact (C2C) more >



Investigational antibody treatment yields exciting though preliminary results

September 1, 2016
Nature

A paper published August 31 in Nature, describes that Biogen Idec’s candidate treatment, aducanumab, reduced amyloid-β in the brains of patients with early-stage Alzheimer’s disease. Patients receiving the highest doses of the medicine in the Phase IB trial had the largest reductions in brain amyloid and also declined the least in clinical assessments.

more >


Featured Conference Topic: The Oldest Old, 90+

The EARLYBIRD deadline for the research conference is quickly approaching! Register online before September 9 and SAVE!

90+What allows people to live to age 90 and beyond?

How does memory loss affect those in their 90’s? How do people remain #dementia-free into their 90’s?

more >


Gene Wilder passes away from complications of Alzheimer’s disease

Mandatory Credit: Photo by STEVE WOOD/REX/Shutterstock (74497b) GENE WILDER VARIOUS - 1979

(Steve Wood/Rex/Shutterstock)

August 30, 2016
Huffington Post

We are deeply saddened by the passing of beloved actor Gene Wilder yesterday. His family confirmed Alzheimer’s disease as the cause of death, helping to lift the “veil of stigma about the most common cause of dementia.” more >



Sept 30 Research Conference – Featured Topic: Caregiver Panel

Picture1Caring for a loved one with dementia poses unique challenges based on the specific diagnosis.

Dr. Jill Shapira, a researcher and practitioner in the field of dementia caregiving, will moderate a diverse panel of dementia caregivers, including the wife of a husband with Lewy body dementia, the wife of a husband with frontotemporal dementia, the mother of a daughter with Down syndrome and Alzheimer’s disease, and the daughter of a parent with Alzheimer’s disease. more >